Agenus (AGEN) Other Accumulated Expenses (2010 - 2026)
Agenus (AGEN) posted quarterly Other Accumulated Expenses of $514000.0 for Q1 2026, down 89.76% year-over-year from $5.0 million in Q1 2025, and down 2.84% quarter-over-quarter from $529000.0 in Q4 2025.
Analysis
Agenus (AGEN) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
Agenus' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $514000.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 89.76% year-over-year to $514000.0; the TTM figure through Mar 2026 stood at $514000.0 (down 89.76% YoY), while the FY2025 annual figure was $529000.0, down 93.23% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $514000.0, down from $529000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $14.0 million in Q1 2024, with the low at $514000.0 in Q1 2026.
- The 5-year median for Other Accumulated Expenses is $7.3 million (2024), against an average of $7.7 million.
- The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses soared 260.16% in 2023, then sank 93.23% in 2025.
- Agenus' Other Accumulated Expenses stood at $11.5 million in 2022, then advanced by 21.45% to $13.9 million in 2023, then plunged by 43.82% to $7.8 million in 2024, then tumbled by 93.23% to $529000.0 in 2025, then fell by 2.84% to $514000.0 in 2026.
- Business Quant data shows AGEN's Other Accumulated Expenses at $514000.0 in Q1 2026, $529000.0 in Q4 2025, and $7.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.43 Mn |
| Mar 31, 2026 | 5.61 Mn |
| Dec 31, 2025 | 9.11 Mn |
| Sep 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Mar 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Sep 30, 2024 | 12.57 Mn |
| Jun 30, 2024 | 16.34 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 13.92 Mn |
| Sep 30, 2023 | 13.42 Mn |
| Jun 30, 2023 | 13.27 Mn |
| Mar 31, 2023 | 12.94 Mn |
| Dec 31, 2022 | 11.46 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 6.36 Mn |
| Dec 31, 2021 | 7.08 Mn |
| Sep 30, 2021 | 6.78 Mn |